发明名称 |
FORMULATION COMPRISING PHENYLAMINOPYRIMIDINE DERIVATIVE AS ACTIVE AGENT |
摘要 |
An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs such as Form I, Form II and Form III thereof to improve the bioavailability intended for self-emulsification upon its contact with the gastro-intestinal fluid. The invention also relates to a process for the preparation of oral solution containing NRC-AN-019 in an effective concentration for the better therapy against Chronic Myeloid Leukemia as BCR-ABL tyrosine kinase inhibitor and against other tumors such as head and neck cancer, prostate cancer and the like. |
申请公布号 |
HUE025562(T2) |
申请公布日期 |
2016.03.29 |
申请号 |
HUE11764851 |
申请日期 |
2011.08.10 |
申请人 |
Natco Pharma Limited |
发明人 |
PARVATANENI, Durga Maheswari;YEDLURI, Siddhartha;APPADWEDULA, Venkata Satyanarayana;ADIBHATLA, Kali Satya Bhujanga Rao;NANNAPANENI, Venkaiah Chowdary |
分类号 |
A61K9/08;A61K9/14;A61K9/48 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|